Dominique Tersago
Chief Tech/Sci/R&D Officer bij CANTARGIA AB
Vermogen: - $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Dominique Tersago
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
18
| Subsidiary | Biotechnology | 18 |
17
| Public Company | Pharmaceuticals: Major | 17 |
Exevir Bio BV
 Exevir Bio BV Pharmaceuticals: MajorHealth Technology Exevir Bio BV is engaged in biotechnology services. The company is headquartered in Zwijnaarde, Belgium.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Dominique Tersago via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| CONSORT MEDICAL PLC | Pharmaceuticals: Major | Director/Board Member Chairman | |
| AEROCRINE AB | Electronic Equipment/Instruments | Founder | |
| ABLIVA AB | Pharmaceuticals: Major | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GENMAB A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member Investor Relations Contact Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Pharmaceuticals: Generic | Chief Executive Officer Director/Board Member | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chairman Chief Executive Officer | |
| University of Stockholm | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Lund | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Undergraduate Degree Doctorate Degree | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| Healthcap III Sidefund GP AB | Investment Managers | Director/Board Member | |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| MOBERG PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| KCIF Fund Management AB | Director/Board Member | ||
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Chairman Investor Relations Contact | |
Attgeno AB
 Attgeno AB Pharmaceuticals: MajorHealth Technology ATTGENO AB develops, manufactures, and trades pharmaceutical drugs and electronic apparatus. Its product, Supernitro, is a vasodilator indicated for the treatment of acute pulmonary hypertension associated with major cardiac surgery. The company is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman Chief Executive Officer Director/Board Member | |
| MENDUS AB | Biotechnology | Director/Board Member Director/Board Member | |
| CIRCIO HOLDING ASA | Biotechnology | Chairman Director/Board Member | |
| Theralpha | Director/Board Member | ||
| BIOTALYS NV | Chemicals: Agricultural | Director/Board Member Director/Board Member | |
Loxbridge Research LLP
 Loxbridge Research LLP Financial ConglomeratesFinance Loxbridge Research LLP operates as an investment and project management company. It specializes in startup, early stage, and later stage investments in growth stage companies. The firm supports scientists and focuses on sectors like science, medicine and healthcare technology particularly biotech, med-tech, noval therapeutic, diagnostics, cancer, infectious diseases, neurodegeneration, imaging hardware and software, and enabling devices. The company was founded by Charles Roberts in 2008 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
Agalimmune Ltd.
 Agalimmune Ltd. Pharmaceuticals: MajorHealth Technology Part of BioLineRx Ltd., Agalimmune Ltd. is a British company that develops anti-cancer immunotherapy technology. The private company is based in London, UK. The company was founded by Charles Campbell Roberts and Graham Griffiths. The CEO is Mike Westby. Agalimmune was acquired by BioLineRx Ltd. on March 23, 2017 for $6.05 million. | Pharmaceuticals: Major | Director/Board Member | |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Chairman Director/Board Member | |
Resolys Bio, Inc.
 Resolys Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Resolys Bio, Inc. operates as a pharmaceutical company. The firm develops OSLO and MCC for the treatment of certain forms of traumatic brain injury and chronic painful tissue disorders. The company is headquartered in Delanson, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Själbådan AB
 Själbådan AB Financial ConglomeratesFinance Själbådan AB is a private company based in Stockholm, Sweden that provides investment services. | Financial Conglomerates | Director/Board Member | |
Gyros Protein Technologies Holding AB
 Gyros Protein Technologies Holding AB Electronic Equipment/InstrumentsElectronic Technology Part of Mesa Laboratories, Inc., Gyros Protein Technologies Holding AB is a Swedish company that manufactures measurement, testing and navigation equipment. The private company is based in Stockholm, Sweden. | Electronic Equipment/Instruments | Director/Board Member | |
Perma Ventures AB
 Perma Ventures AB Investment ManagersFinance Perma Ventures AB provides financial advisory services. The private company is based in Stockholm, Sweden. | Investment Managers | Director/Board Member | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
ADDI Medical AB
 ADDI Medical AB Packaged SoftwareTechnology Services ADDI Medical AB develops a communication platform for the healthcare industry. The private company is based in Stockholm, Sweden. | Packaged Software | Director/Board Member | |
| Addi Optioner AB | Director/Board Member | ||
| GALECTO, INC. | Pharmaceuticals: Major | Chairman |
Statistieken
Internationaal
| Zweden | 23 |
| Verenigd Koninkrijk | 7 |
| België | 7 |
| Frankrijk | 6 |
| Denemarken | 5 |
Sectoraal
| Health Technology | 25 |
| Finance | 9 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Electronic Technology | 3 |
Operationeel
| Director/Board Member | 257 |
| Chairman | 88 |
| Independent Dir/Board Member | 82 |
| Corporate Officer/Principal | 71 |
| Chief Executive Officer | 33 |
Sterkste connecties
- Beurs
- Insiders
- Dominique Tersago
- Bedrijfsconnecties
